Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may lead to functional decline and falls. This study compared objective and self-report measures of physical function, gait patterns, and falls between women cancer survivors with and without symptoms of CIPN to identify targets for functional rehabilitation. Methods A secondary data analysis of 512 women cancer survivors (age, 62 6 6 years; time since diagnosis, 5.8 6 4.1 years) categorized and compared women self-reporting symptoms of CIPN (CIPN+) with asymptomatic women (CIPN2) on the following: maximal leg strength, timed chair stand, physical function battery, gait characteristics (speed; step number, rate, and length; base of suppor...
OBJECTIVE:Breast cancer treatment, including radical surgery, is also pursued as late as the 7th - 8...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially reversible si...
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may l...
Objective: We investigated the incidence of falls and functional impairments in breast cancer patien...
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and...
Limited information exists on the effects of self-reported exercise on subjective and objective meas...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant and often lasting sid...
Chemotherapy induced peripheral neuropathy (CIPN) is a crippling side effect of some types of chemot...
Twelve percent of women suffer from breast cancer each year, but survivorship is increasing due to i...
Objective:An essential component for optimizing quality of life in adults with cancer is determining...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced-peripheral...
Background Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effect...
Objective—To identify neuromuscular, balance and vision factors that contribute to falls in recently...
OBJECTIVE:Breast cancer treatment, including radical surgery, is also pursued as late as the 7th - 8...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially reversible si...
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may l...
Objective: We investigated the incidence of falls and functional impairments in breast cancer patien...
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and...
Limited information exists on the effects of self-reported exercise on subjective and objective meas...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant and often lasting sid...
Chemotherapy induced peripheral neuropathy (CIPN) is a crippling side effect of some types of chemot...
Twelve percent of women suffer from breast cancer each year, but survivorship is increasing due to i...
Objective:An essential component for optimizing quality of life in adults with cancer is determining...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced-peripheral...
Background Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effect...
Objective—To identify neuromuscular, balance and vision factors that contribute to falls in recently...
OBJECTIVE:Breast cancer treatment, including radical surgery, is also pursued as late as the 7th - 8...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially reversible si...